Industry Leaders Debate Big Pharma R&D (Too Little Hope?) and Stem Cell Research (Too Much hype?)

Different points on the research spectrum were under the microscope at the Wharton Health Care Business Conference last month as two panels of biotech, pharmaceutical and investment leaders discussed the state of R&D among big pharmaceuticals and the progress of stem cell research. While disappo...

Full description

Saved in:

Bibliographic Details
Main Author:	Knowledge@SMU
Format:	text
Language:	English
Published:	Institutional Knowledge at Singapore Management University 2006
Subjects:	Economics Health Economics Social and Behavioral Sciences
Online Access:	https://ink.library.smu.edu.sg/ksmu/98 https://ink.library.smu.edu.sg/cgi/viewcontent.cgi?article=1097&context=ksmu
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Singapore Management University
Language:	English

id	sg-smu-ink.ksmu-1097
record_format	dspace
spelling	sg-smu-ink.ksmu-10972018-07-04T09:39:25Z Industry Leaders Debate Big Pharma R&D (Too Little Hope?) and Stem Cell Research (Too Much hype?) Knowledge@SMU Different points on the research spectrum were under the microscope at the Wharton Health Care Business Conference last month as two panels of biotech, pharmaceutical and investment leaders discussed the state of R&D among big pharmaceuticals and the progress of stem cell research. While disappointing results in both sectors have dominated the news lately, panelists at each session also noted some promising developments -- and causes for optimism -- in their respective fields. 2006-03-01T08:00:00Z text application/pdf https://ink.library.smu.edu.sg/ksmu/98 https://ink.library.smu.edu.sg/cgi/viewcontent.cgi?article=1097&context=ksmu http://creativecommons.org/licenses/by-nc-nd/4.0/ Knowledge@SMU eng Institutional Knowledge at Singapore Management University Economics Health Economics Social and Behavioral Sciences
institution	Singapore Management University
building	SMU Libraries
country	Singapore
collection	InK@SMU
language	English
topic	Economics Health Economics Social and Behavioral Sciences
spellingShingle	Economics Health Economics Social and Behavioral Sciences Knowledge@SMU Industry Leaders Debate Big Pharma R&D (Too Little Hope?) and Stem Cell Research (Too Much hype?)
description	Different points on the research spectrum were under the microscope at the Wharton Health Care Business Conference last month as two panels of biotech, pharmaceutical and investment leaders discussed the state of R&D among big pharmaceuticals and the progress of stem cell research. While disappointing results in both sectors have dominated the news lately, panelists at each session also noted some promising developments -- and causes for optimism -- in their respective fields.
format	text
author	Knowledge@SMU
author_facet	Knowledge@SMU
author_sort	Knowledge@SMU
title	Industry Leaders Debate Big Pharma R&D (Too Little Hope?) and Stem Cell Research (Too Much hype?)
title_short	Industry Leaders Debate Big Pharma R&D (Too Little Hope?) and Stem Cell Research (Too Much hype?)
title_full	Industry Leaders Debate Big Pharma R&D (Too Little Hope?) and Stem Cell Research (Too Much hype?)
title_fullStr	Industry Leaders Debate Big Pharma R&D (Too Little Hope?) and Stem Cell Research (Too Much hype?)
title_full_unstemmed	Industry Leaders Debate Big Pharma R&D (Too Little Hope?) and Stem Cell Research (Too Much hype?)
title_sort	industry leaders debate big pharma r&d (too little hope?) and stem cell research (too much hype?)
publisher	Institutional Knowledge at Singapore Management University
publishDate	2006
url	https://ink.library.smu.edu.sg/ksmu/98 https://ink.library.smu.edu.sg/cgi/viewcontent.cgi?article=1097&context=ksmu
_version_	1681132806436028416

Industry Leaders Debate Big Pharma R&D (Too Little Hope?) and Stem Cell Research (Too Much hype?)

Similar Items